ArticleCureus2025
Effects of Essential Amino Acid Supplementation on Clinical Outcomes in the Conservative Management of Knee Osteoarthritis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe effect of supplementation of essential amino acids (EAAs) in knee osteoarthritis (OA) remains unclear. This study aimed to evaluate whether supplementation with EAA improves pain, patient-reported outcome measures, gait function, and quadriceps muscle volume in patients undergoing conservative treatment for knee OA.
methodsA retrospective cohort study was conducted on outpatients undergoing physical therapy from April 2024 to March 2025. Inclusion criteria were patients who started physical therapy for knee OA, with exclusion of patients taking other supplements or having severe medical conditions. Patients who received EAA at the beginning of physical therapy were assigned to the EAA group (8 g/day supplementation), while those who did not were assigned to the control group. The primary outcome was the maximum value on the visual analogue scale (VAS). Secondary outcomes included the Knee injury and Osteoarthritis Outcome Score (KOOS) subscales, gait speed and steps, quadriceps torque, and quadriceps volume measured at baseline and 12 weeks.
resultsOf the 51 patients initially included, 36 patients were ultimately analyzed (EAA group: n = 17, control group: n = 19). No significant differences were observed in VAS, KOOS subscales, and quadriceps torque between groups. However, the EAA group demonstrated significantly greater improvements in 6-meter gait speed, step count, and quadriceps volume compared to the control group. No adverse effects were observed associated with EAA supplementation.
conclusionsEAA supplementation in the conservative treatment of knee OA demonstrated significant improvements in gait function and quadriceps muscle volume compared to the control group. These results suggest the efficacy of EAA supplementation in the conservative management of knee OA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.